Mosaic trisomy 16 ascertained through amniocentesis: evaluation of 11 new cases. 1998

W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
Department of Pediatrics, Rush Medical College, Chicago, Illinois, USA. whsu@rush.edu

Trisomy 16, once thought to result uniformly in early pregnancy loss, has been detected in chorionic villus samples (CVS) from on-going pregnancies and was initially ascribed to a second, nonviable pregnancy. Prenatally detected trisomy 16 in CVS and its resolution to disomy has led to the reexamination of the viability of trisomy 16. This study evaluates 11 cases of mosaic trisomy 16 detected through second trimester amniocentesis. In 9 of the 11 cases, amniocenteses were performed in women under the age of 35 because of abnormal levels of maternal serum alpha-fetoprotein (MSAFP) or maternal serum human chorionic gonadotropin (MShCG). The other two amniocenteses were performed for advanced maternal age. Five of the 11 pregnancies resulted in liveborn infants, and six pregnancies were electively terminated. The liveborn infants all had some combination of intrauterine growth retardation (IUGR), congenital heart defects (CHD), or minor anomalies. Two of them died neonatally because of complications of severe congenital heart defects. The three surviving children have variable growth retardation, developmental delay, congenital anomalies, and/or minor anomalies. In the terminated pregnancies, the four fetuses evaluated by ultrasound or autopsy demonstrated various congenital anomalies and/or IUGR. Cytogenetic and fluorescent in situ hybridization studies identified true mosaicism in 5 of 10 cases examined, although the abnormal cell line was never seen in more than 1% of cultured lymphocytes. Placental mosaicism was seen in all placentas examined and was associated with IUGR in four of seven cases. Maternal uniparental disomy was identified in three cases. Mosaic trisomy 16 detected through amniocentesis is not a benign finding but associated with a high risk of abnormal outcome, most commonly IUGR, CHD, developmental delay, and minor anomalies. The various outcomes may reflect the diversity of mechanisms involved in the resolution of this abnormality. As 80% of these patients were ascertained because of the presence of abnormal levels of MSAFP or MShCG, the increased use of maternal serum screening should bring more such cases to clinical attention.

UI MeSH Term Description Entries
D009030 Mosaicism The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D002885 Chromosomes, Human, Pair 16 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 16
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000509 alpha-Fetoproteins The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life. alpha-Fetoprotein,alpha Fetoprotein,alpha Fetoproteins
D000649 Amniocentesis Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions. Amniocenteses
D014314 Trisomy The possession of a third chromosome of any one type in an otherwise diploid cell. Partial Trisomy,Chromosomal Triplication,Chromosomal Triplications,Partial Trisomies,Trisomies,Trisomies, Partial,Trisomy, Partial
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH

Related Publications

W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
July 2009, American journal of medical genetics. Part A,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
June 1992, Prenatal diagnosis,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
January 1989, Journal de genetique humaine,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
November 2005, Prenatal diagnosis,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
November 2006, Prenatal diagnosis,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
September 2019, Taiwanese journal of obstetrics & gynecology,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
September 2013, Taiwanese journal of obstetrics & gynecology,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
October 1989, Lancet (London, England),
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
January 1980, Human genetics,
W T Hsu, and D A Shchepin, and R Mao, and E Berry-Kravis, and A P Garber, and N Fischel-Ghodsian, and R E Falk, and D E Carlson, and E R Roeder, and E A Leeth, and M J Hajianpour, and J C Wang, and L S Rosenblum-Vos, and S D Bhatt, and E M Karson, and C H Hux, and C Trunca, and M G Bialer, and S K Linn, and R R Schreck
July 1996, Human genetics,
Copied contents to your clipboard!